Efficacy of Iodine Complex Against COVID-19 Patients

• Status: Recruiting
• Trial end date: 2021-10-15
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sohaib Ashraf
• Collaborator: MTI Medical Private Limited, Pakistan
• Treatments: Cadexomer iodine; Iodine

Criteria

Inclusion Criteria:

• Positive PCR with mild to moderate disease

Exclusion Criteria:

• Allergic to iodine

• Any co-morbidity other than hypertension and dietetics